Global Mental Health
& Well-Being

ental health impacts the physical, social, and economic health of individuals and societies worldwide. More than three-quarters of people suffering from mental illness live in low- and middle-income countries (LMICs), where many lack access to quality mental health care. In fact, more than 75% of people with mental health disorders in LMICs receive no care at all.

For more than 60 years, Johnson & Johnson has been dedicated to improving outcomes for those suffering from mental illness. Our involvement began in the 1950s, when Dr. Paul Janssen's research led to a revolutionary breakthrough treatment for schizophrenia. Over the last half century, the Janssen Pharmaceutical Companies of Johnson & Johnson has discovered, developed and launched many innovative treatments for conditions impacting the brain and central nervous system. Now, we are building on this legacy by expanding access to mental health care for the world’s most vulnerable and underserved populations, starting in Rwanda. In addition, we are supporting mental health programs that are providing resources to support frontline health workers around the world.

expand

expand

he Johnson & Johnson Foundation, guided by our Center for Health Worker Innovation, has also supported a number of partners and programs providing psychosocial and well-being resources for frontline health workers as part of $300 million in commitments over 10 years to support the health workforce made by the Johnson & Johnson Family of Companies and the Johnson & Johnson Foundation. We believe the well-being of those who deliver care is essential to improving access to quality healthcare, and COVID-19 has only exacerbated the stresses health workers face: risk of infection, workload, medical supply shortages, depletion of personal protective equipment, losing patients and colleagues, and the fear of infecting family and friends.

One example of this is how Johnson & Johnson Medical Devices and the Johnson & Johnson Family of Companies are stepping up to support those at the frontlines of delivering care in Brazil. In partnership with the Distrito Innovation Hub and Moodar and TNH health techs, "Caring for Those Who Care for Us" offers emotional and psychotherapy support using Vitalk, an AI chatbot, and provides a limited online psychotherapy program consultation to healthcare workers who are in the fight against COVID-19. More than 5,000 thousand healthcare workers have benefited. In addition, in order to promote the well-being and greater resilience of the frontline workers, Johnson & Johnson Family of Companies in Brazil is partnering with the Institute for Healthcare Improvement (IHI), in a program that will apply the science of improvement to improve physical and psychological safety, wellness, and resilience of healthcare providers in Brazil.

expand

cience Over Stigma (SOS) is a new global coalition of public, private, and non-governmental organizations committed to ending stigma related to mental health challenges. Together with our partners, we are bringing together advocacy, social and biologic sciences, and arts and culture to:

• Speak with one voice by integrating the fragmented ecosystem of mental health initiatives and identifying new opportunities for collective impact;

• Demystify mental illness by working together to drive understanding of its physiologic aspects; and

• Engage hearts and minds by fueling fresh dialog about stigma and mental health through storytelling and expressive arts.

For more information contact the Office of the Chief Scientific Officer.